Glycomet Trio 2/0.3 Tablet SR
Marketer
USV Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glycomet Trio 2/0.3 Tablet SR
This medication, Glycomet Trio 2/0.3 Tablet SR, is an antidiabetic combination drug used in adult patients with type 2 diabetes. Its purpose is to regulate blood glucose levels. Administer this medicine with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels and risk kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect; recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with readily available glucose. Maintain regular mealtimes and carry a fast-acting sugar source. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medicine is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your physician, is necessary.
Primary Ingredients of Glycomet Trio 2/0.3 Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glycomet Trio 2/0.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Glycomet Trio 2/0.3 Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycomet Trio 2/0.3 Tablet SR should be consumed on an empty stomach.
Common Side effects of Glycomet Trio 2/0.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glycomet Trio 2/0.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glycomet Trio 2/0.3 Tablet SR whole; do not break, crush, or chew it. Administer on an empty stomach.
How Glycomet Trio 2/0.3 Tablet SR works:
Glycomet Trio SR tablets (2mg/0.3mg) contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glycomet Trio 2/0.3 Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Glycomet Trio 2/0.3 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glycomet Trio 2/0.3 tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Glycomet Trio 2/0.3 SR tablets pose a likely risk for individuals with kidney impairment and should be omitted. Medical advice is necessary. The use of Glycomet Trio 2/0.3 SR tablets is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Glycomet Trio 2/0.3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glycomet Trio 2/0.3 Tablet SR is typically initiated at a low dose; however, its use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glycomet Trio 2/0.3 Tablet SR :
Should you forget a Glycomet Trio 2/0.3 Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glycomet Trio 2/0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently